Authors:
Balch, CM
Soong, SJ
Gershenwald, JE
Thompson, JF
Reintgen, DS
Cascinelli, N
Urist, M
McMasters, KM
Ross, MI
Kirkwood, JM
Atkins, MB
Thompson, JA
Coit, DG
Byrd, D
Desmond, R
Zhang, YT
Liu, PY
Lyman, GH
Morabito, A
Citation: Cm. Balch et al., Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system, J CL ONCOL, 19(16), 2001, pp. 3622-3634
Authors:
Balch, CM
Buzaid, AC
Soong, SJ
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Gershenwald, JE
Houghton, A
Kirkwood, JM
McMasters, KM
Mihm, MF
Morton, DL
Reintgen, DS
Ross, MI
Sober, A
Thompson, JA
Thompson, JF
Citation: Cm. Balch et al., Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma, J CL ONCOL, 19(16), 2001, pp. 3635-3648
Authors:
Arani, RB
Soong, SJ
Weiss, HL
Wood, MJ
Fiddian, PA
Gnann, JW
Whitley, R
Citation: Rb. Arani et al., Phase specific analysis of herpes zoster associated pain data: a new statistical approach, STAT MED, 20(16), 2001, pp. 2429-2439
Authors:
Kimberlin, DW
Lin, CY
Jacobs, RF
Powell, DA
Frenkel, LM
Gruber, WC
Rathore, M
Bradley, JS
Diaz, PS
Kumar, M
Arvin, AM
Gutierrez, K
Shelton, M
Weiner, LB
Sleasman, JW
de Sierra, TM
Soong, SJ
Kiell, J
Lakeman, FD
Whitley, RJ
Citation: Dw. Kimberlin et al., Natural history of neonatal herpes simplex virus infections in the acyclovir era, PEDIATRICS, 108(2), 2001, pp. 223-229
Authors:
Kimberlin, DW
Lin, CY
Jacobs, RF
Powell, DA
Corey, L
Gruber, WC
Rathore, M
Bradley, JS
Diaz, PS
Kumar, M
Arvin, AM
Gutierrez, K
Shelton, M
Weiner, LB
Sleasman, JW
de Sierra, TM
Weller, S
Soong, SJ
Kiell, J
Lakeman, FD
Whitley, RJ
Citation: Dw. Kimberlin et al., Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections, PEDIATRICS, 108(2), 2001, pp. 230-238
Authors:
Balch, CM
Soong, SJ
Ross, MI
Urist, MM
Karakousis, CP
Temple, WJ
Mihm, MC
Barnhill, RL
Jewell, WR
Wanebo, HJ
Harrison, R
Citation: Cm. Balch et al., Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm), ANN SURG O, 7(2), 2000, pp. 87-97
Authors:
Spitler, LE
Grossbard, ML
Ernstoff, MS
Silver, G
Jacobs, M
Hayes, FA
Soong, SJ
Citation: Le. Spitler et al., Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor, J CL ONCOL, 18(8), 2000, pp. 1614-1621
Authors:
Balch, CM
Buzaid, AC
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Houghton, A
Kirkwood, JM
Mihm, MF
Morton, DL
Reintgen, D
Ross, MI
Sober, A
Soong, SJ
Thompson, JA
Thompson, JF
Gershenwald, JE
McMasters, KM
Citation: Cm. Balch et al., A new American Joint Committee on Cancer staging system for cutaneous melanoma, CANCER, 88(6), 2000, pp. 1484-1491
Authors:
Beenken, SW
Krontiras, H
Maddox, WA
Peters, GE
Soong, SJ
Urist, MM
Citation: Sw. Beenken et al., T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection, HEAD NECK, 21(2), 1999, pp. 124-130